Preclinical biotech developing engineered cell therapies for multiple indications.
Industry: Health Care
First Day Return: +40.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/13/2021 |
Offer Price | $25.00 |
Price Range $23.00 - $24.00 | |
Offer Shares (mm) | 23.5 |
Deal Size ($mm) | $588 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/03/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $588 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Seattle, WA, United States |
Founded | 2018 |
Employees at IPO | 240 |
Website www.sana.com |